Download PDF
Hamostaseologie 2002; 22(02): 55-56
DOI: 10.1055/s-0037-1619541
In memoriam I. Witt
Schattauer GmbH

Fibrinolyse bei Dysfibrinogenämien

I. Witt
1   Universitäts-Kinderklinik Freiburg i. Br.
› Author Affiliations
Further Information

Publication History

Publication Date:
27 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Rupp C, Beck EA. Congenital dysfibrinogenemia. In: Beck EA, Furlan M. (Hrsg). Variants of human fibrinogen. Bern, Stuttgart, Toronto: Hans Huber; 1984: 65-130.
    Google Scholar
  • 2 Samama M, Conard J, Soria J. Congential dysfibrinogenemia and thrombosis. Fibrinolysis 1988; 2 (Suppl. 02) 18-23.
    PubMedGoogle Scholar
  • 3 Matsuda M. Molecular abnormalities of fibrinogen. Thromb Haemost 1989; 62: SA-11.
    PubMedGoogle Scholar
  • 4 Koopman J, Haverkate F, Lord S, Caekebeke-Peelinck K, Brommer E, Briet E. A six base deletion in the γchain gene of dysfibrinogen Vlissingen, coding for Asn 319 and Asp 320, resulting in defective interaction with Ca2+ . Thromb Haemost 1989; 62: A470.
    PubMedGoogle Scholar
  • 5 Yonekawa O, Vermond A, Nieuwenhuizen W. Localisation of a new site in fibrin, involved in acceleration of t-PA mediated activation of plasminogen. Thromb Haemost 1989; 62: A194.
    PubMedGoogle Scholar
  • 6 Holm B, Godal HC. Quantitation of the three normally occurring plasma fibrinogens in health and during socalled “acute phase” by SDS electrophoresis of fibrin obtained from EDTA-plasma. Thromb Res 1984; 35: 279-90.
    CrossrefPubMedGoogle Scholar
  • 7 Witt I. Lysis resistance of fibrin clots under postoperative acute phase conditions. Haemostasis 1986; 16 (Suppl. 05) 37.
    PubMedGoogle Scholar
  • 8 Witt I, Schöndorf TH, Franz K, Weber U. Veränderungen der Fibrinolyse nach Hüftgelenkseingriffen und ihre Bedeutung als Risikofaktoren für postoperative Thrombosen. In: Weber U, Schöndorf TH. (Hrsg). Aktuelle Probleme in der Orthopädie und Traumatologie. Stuttgart, New York: Thieme; 1988: 32-7.
    Google Scholar